SG Americas Securities’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-16,742
| Closed | -$116K | – | 3081 |
|
|
2024
Q4 | $116K | Buy |
16,742
+6,323
| +61% | +$43.8K | ﹤0.01% | 2335 |
|
|
2024
Q3 | $55K | Buy |
+10,419
| New | +$55K | ﹤0.01% | 2852 |
|
|
2024
Q1 | – | Sell |
-12,257
| Closed | -$69K | – | 2737 |
|
|
2023
Q4 | $69K | Sell |
12,257
-1,609
| -12% | -$9.06K | ﹤0.01% | 2602 |
|
|
2023
Q3 | $66K | Buy |
+13,866
| New | +$66K | ﹤0.01% | 2598 |
|
|
2023
Q2 | – | Sell |
-13,411
| Closed | -$104K | – | 2277 |
|
|
2023
Q1 | $104K | Buy |
13,411
+2,779
| +26% | +$21.6K | ﹤0.01% | 2635 |
|
|
2022
Q4 | $81K | Buy |
+10,632
| New | +$81K | ﹤0.01% | 2512 |
|
|
2022
Q3 | – | Sell |
-11,319
| Closed | -$109K | – | 2910 |
|
|
2022
Q2 | $109K | Buy |
+11,319
| New | +$109K | ﹤0.01% | 2802 |
|
|
2022
Q1 | – | Sell |
-6,621
| Closed | -$135K | – | 2733 |
|
|
2021
Q4 | $135K | Sell |
6,621
-617
| -9% | -$12.6K | ﹤0.01% | 2605 |
|
|
2021
Q3 | $161K | Buy |
+7,238
| New | +$161K | ﹤0.01% | 3111 |
|